XOMA Corp Intellectual Property Contracts & Agreements

18 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement, dated June 10, 2015, between ObsEva, SA and Ares Trading S.A
License Agreements
XOMA Corp
Biotechnology
2023
License Agreement, dated July 26, 2021, between ObsEva, SA and Organon International GmbH
License Agreements
XOMA Corp
Biotechnology
NY
2023
License Agreement, dated March 23, 2016, between XOMA Corporation and Ology Bioservices Inc. (formerly Nanotherapeutics Inc., now a wholly owned subsidiary of National Resilience,...
License Agreements
XOMA Corp
Biotechnology
CA
2022
License Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG
License Agreements
XOMA Corp
Biotechnology
DE
2022
IL-1b Target License Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG
License Agreements
XOMA Corp
Biotechnology
NY
2022
Amendment No. 1, dated July 24, 2020, to the Non-Exclusive License Agreement, dated November 30, 2001, between XOMA Ireland Limited ("XOMA") and Sesen Bio, Inc
License Agreements
XOMA Corp
Biotechnology
2021
Non-Exclusive License Agreement, dated November 30, 2001, between XOMA Ireland Limited ("XOMA") Sesen Bio, Inc. and (formerly Viventia Biotech Inc.)
License Agreements
XOMA Corp
Biotechnology
CA
2021
License Agreement between the Company and Novartis International Pharmaceutical Ltd., dated September 30, 2015 (this exhibit was previously filed under confidential treatment...
License Agreements
XOMA Corp
Biotechnology
NY
2020
Amendment No. 2, dated January 7, 2019, to the License Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio)
License Agreements
XOMA Corp
Biotechnology
CA
2019
Amendment No. 1, dated March 30, 2018, to the License Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio, Inc.)
License Agreements
XOMA Corp
Biotechnology
2018
License Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio)
License Agreements
XOMA Corp
Biotechnology
CA
2018
License Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG
License Agreements
XOMA Corp
Biotechnology
DE
2017
IL-1b Target License Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG
License Agreements
XOMA Corp
Biotechnology
DE
2017
EXCLUSIVE LICENSE AGREEMENT
License Agreements
XOMA Corp
Biotechnology
NY
2016
LICENSE AGREEMENT by and between XOMA (US) LLC and NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. Table of Contents (continued)
License Agreements
XOMA Corp
Biotechnology
NY
2015
First Amendment, dated October 28, 2014, to the License Agreement between XOMA (US) LLC (assigned to it by XOMA Ireland Limited) and BP Biofuels Advanced Technology Inc....
License Agreements
XOMA Corp
Biotechnology
2014
[*] indicates that a confidential portion of the text of this agreement has been omitted. AMENDED ANDRESTATED LICENSE AGREEMENT
License Agreements
XOMA Corp
Biotechnology
NY
2007
LICENSE AGREEMENT
License Agreements
XOMA Corp
Biotechnology
NY
2005